Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study
Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…Mild Cognitive Impairment in Parkinson’s disease in South Indian population – Development of a test battery and assessment of prevalence and characteristics
Objective: We aimed to design a neuropsychological test battery to diagnose Mild Cognitive Impairment (MCI) and to estimate the prevalence of MCI in Malayalam-speaking patients…Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats
Objective: This study assessed the neuroprortective effects of combination of CoQ10 with vitamin E in Chronic Cerebral Hypoperfusion-induced neurodegeration (CCH-ND) model of rat. Background: Alzheimer’s…Praxis deficits in patients with Parkinson’s disease: A neuropsychological study
Objective: 1. To identify presence and subtypes of apraxia in patients with idiopathic Parkinson’s Disease. 2. To relate praxis deficits in IPD to clinical UPDRS,…Prodromal symptoms in clinically diagnosed dementia with Lewy bodies stratified by Lewy body pathology on autopsy
Objective: Compare prodromal neuropsychiatric, sleep, and motor symptoms in patients clinically diagnosed with dementia with Lewy bodies (DLB) with and without Lewy body pathology on…Evaluation of nigral neuronal apoptosis during postnatal development and adulthood of mice strains with differential sensitivity to MPTP
Objective: Compare nigral neurons in C57BL/6J, CD-1 and their F1 crossbreds with respect to developmental apoptosis in the nigra during postnatal and to assess MPTP-induced…Mitigation Effects of a Novel Herbal Medicine Hepad, on neurophysiology.
Objective: Therefore, further studies are needed to identify compounds that can modulate the disease process and prevent the progression of symptoms in affected patients. Our…Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease
Objective: To describe the longitudinal relation between dopaminergic agonists (DA) use and change of BMI in a longitudinal cohort of PD patients followed annually up…Inflammatory Conditions in Parkinson’s Disease
Objective: The goal was to conduct a case-control study to assess associations between Parkinson disease (PD) and inflammatory conditions including allergies, asthma, eczema, atopic conditions,…Patterns of Lewy body dementia diagnosis and treatment in Florida
Objective: To characterize the demographic and treatment characteristics for the Lewy body dementia (LBD) population in Florida using a statewide clinical data research network. Background:…
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 217
- Next Page »